Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities

Journal of Intellectual Disability Research

Volumn 40, Issue 4, 1996, Pages 322-329

  Branford, D ^a,b  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b Glenfrith Div of Fosse Health Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; THIORIDAZINE;

ADULT; AGGRESSION; ARTICLE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; HYPERACTIVITY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; STEREOTYPY;

EID: 0029817887     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2788.1996.tb00637.x     Document Type: Article

References (22)

1. Aman M.G., Singh N.N., Stewart A.W. & Field C.J. (1985a) The Aberrant Behaviour Checklist: a behaviour rating scale for the assessment of treatment effect. American Journal of Mental Deficiency 89, 485-91.
2. Aman M.G., Field C.J. & Bridgeman G. (1985b) City wide survey of drug patterns amongst non-institutionalised mentally retarded persons. Applied Research in Mental Retardation 6, 159-71.
3. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. DSMI-III-R. American Psychiatric Association, Washington DC.
4. Branford D. (1994) A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. Journal of Intellectual Disability Research 38, 577-86.
5. Briggs R. (1989) Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow up report. American Journal on Mental Retardation 6, 633-9.
6. Clarke D.J., Kelly S., Thinn K. & Corbett J.A. (1990) Psychotropic drugs and mental retardation. Journal of Mental Deficiency Research 34, 385-95.
7. Chadsey-Rusch J. & Sprague R.L. (1989) Maladaptive behaviours associated with neuroleptic drug maintenance. American Journal on Mental Retardation 6, 607-17.
8. Ellenor G. & Frisk P. (1977) Pharmacist impact on drug use in an institution for the mentally retarded. American Journal of Hospital Pharmacy 34, 604-8.
9. Fielding L.T., Murphy R.J., Reagan M.W. & Peterson J.L. (1980) An assessment programme to reduce drug use with the mentally retarded. Hospital and Community Psychiatry 31, 771-3.
10. Findholt N. & Emmett C. (1990) Impact of interdisciplinary review on psychotropic drug use with persons who have mental retardation. Mental Retardation 28, 41-6.
11. Glaser B.A. & Morreau L.E. (1986) Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally handicapped persons. American Journal of Mental Deficiency 90, 371-9.
12. Gowdey C., Coleman L. & Crawford E. (1984) Survey of anticonvulsant and neuroleptic drug use in a mental retardation centre in Ontario. In: Prospectives and Progress in Mental Retardation, Vol. 2, (ed. Berg J. M.), pp. 349-56. University Park Press, Baltimore, MD.
13. Heistad G.T., Zimmerman R.L. & Doebler M.I. (1982) Long term usefulness of thioridazine for institutionalized mentally retarded patients. American Journal of Mental Deficiency 87, 243-54.
14. Inoue F. (1982) A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons. Mental Retardation 20, 70-4.
15. Jacobson J (1988) Problem behaviour and psychiatric impairment with a developmentally disabled population III. Psychotropic Medication Research in Developmental Disabilities 9, 23-38.
16. James D. (1983) Monitoring drugs in hospitals for the mentally handicapped. British Journal of Psychiatry 142, 163-5.
17. Lepler S., Hodas A. & Cotter-Mack A. (1993) Implementation of an interdisciplinary psychotropic drug review process for community-based facilities. Mental Retardation 31, 307-15.
18. Luchins D.J., Dojka D. & Hanrahan P. (1993) Factors associated with reduction in antipsychotic dosage in adults with mental retardation. American Journal of Mental Retardation 98(1), 165-75.
19. Matson J. (1988) The P.I.M.R.A. Manual. Louisiana State University, International Diagnostics System Inc., Orland Park, IL.
20. Poindexter A.R. (1989) Psychotropic drug patterns in a large ICF/MR facility. A ten-year experience. American Journal on Mental Retardation 93, 624-6.
21. Reiss S. (1988) Reiss Screen Test Manual. University of Illinois at Chicago, International Diagnostics Systems Inc., Orland Park, IL.
22. White A. (1983) Changing patterns of psychoactive drug use with the mentally retarded. New Zealand Medical Journal 96, 686-8.